Cyclic (3'- O- (6- [sulfo-cyanine5]aminohexylcarbamoyl)guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[3'-[sCya5]-AHC-G(2',5')pA(3',5')p] ), sodium salt
Cyclic (3'- O- (6- [DY-547P1]- aminohexylcarbamoyl)guanosine- (2' −> 5')- monophosphate- adenosine- (3' −> 5')- monophosphate) ( c[3'-[DY-547P1]-AHC-G(2',5')pA(3',5')p] ), sodium salt
2'- / 3'- O- (5- Chloroanthraniloyl)guanosine- 5'- O- triphosphate ( Cl-ANT-GTP ), sodium salt
3'- O- (5- Chloroanthraniloyl)- 2'- deoxyguanosine- 5'- O- triphosphate ( Cl-ANT-dGTP ), sodium salt
3'- O- (5- Chloroanthraniloyl)- 2'- deoxyadenosine- 5'- O- triphosphate ( Cl-ANT-dATP ), sodium salt
Cyclic (1, N⁶- ethenoadenosine monophosphate- guanosine monophosphate) ( c-(ε-ApGp) / ε-3'3'-cGAMP / c[ε-A(3',5')pG(3',5')p] / c[G(3',5')p-ε-A(3',5')p] ), sodium salt
2'- / 3'- O- (5- Bromoanthraniloyl)inosine- 5'- O- triphosphate ( Br-ANT-ITP ), sodium salt
2'- / 3'- O- (5- Bromoanthraniloyl)guanosine- 5'- O- triphosphate ( Br-ANT-GTP ), sodium salt
3'- O- (5- Bromoanthraniloyl)- 2'- deoxyguanosine- 5'- O- triphosphate ( Br-ANT-dGTP ), sodium salt
3'- O- (5- Bromoanthraniloyl)- 2'- deoxyadenosine- 5'- O- triphosphate ( Br-ANT-dATP ), sodium salt
3'- O- Anthraniloyl- 2'- deoxyguanosine- 5'- O- triphosphate ( ANT-dGTP ), sodium salt